|
eBay's PayPal Payments Surge and 3 Hot Stocks Sparking Chatter
Wall St. Cheat Sheet ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD) announced successful top-line results from its pivotal Phase III trial which evaluates the efficacy, tolerability, and safety of pimavanserin in patients diagnosed with Parkinson's disease psychosis, or PDP. |
More: continued here
